Avricore Health Inc.
AVCRF
$0.03
$0.00-3.82%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 1.37M | 2.21M | 2.21M | 2.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1.37M | 2.21M | 2.21M | 2.96M |
| Cost of Revenue | -- | 775.90K | 1.27M | 1.27M | 1.71M |
| Gross Profit | -- | 589.70K | 946.70K | 946.70K | 1.25M |
| SG&A Expenses | -- | 1.17M | 1.37M | 1.37M | 1.30M |
| Depreciation & Amortization | -- | 3.30K | 2.80K | 2.80K | 2.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 1.95M | 2.64M | 2.64M | 3.01M |
| Operating Income | -- | -582.20K | -426.00K | -426.00K | -48.40K |
| Income Before Tax | -- | -1.17M | -1.03M | -1.03M | -654.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -1.17 | -1.03 | -1.03 | -0.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -1.17M | -1.03M | -1.03M | -654.70K |
| EBIT | -- | -582.20K | -426.00K | -426.00K | -48.40K |
| EBITDA | -- | -413.70K | -205.20K | -205.20K | 223.70K |
| EPS Basic | -- | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -- | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | -- | 405.11M | 404.22M | 404.22M | 402.80M |
| Average Diluted Shares Outstanding | -- | 405.11M | 404.22M | 404.22M | 408.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |